Notably, loss of vimentin has been demonstrated to significantly induce proliferation in several cancer cell lines and promote tumor growth in xenograft in vivo models through increased phosphorylation of AKT and upregulation of β-catenin signaling [42]. The gene discussed is AKT1; the disease is cancer.